查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1941153

藥用洗髮精市場－全球產業規模、佔有率、趨勢、機會及預測（依產品類型、銷售管道、地區及競爭格局分類，2021-2031年）

Medicated Shampoo Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Sales Channel, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球藥用洗髮精市場預計將從 2025 年的 267.5 億美元成長到 2031 年的 366.1 億美元，複合年成長率為 5.37%。

此細分市場主要指含有活性成分的治療性護髮配方，這些活性成分專門用於治療頭皮屑、乾癬和脂漏性皮膚炎等頭皮問題。推動市場成長的關鍵因素包括頭皮問題日益增多以及消費者在具有特定健康功效的功能性個人保健產品上的支出不斷成長。根據歐洲化妝品協會（Cosmetics Europe）的數據，預計到2024年，歐洲護髮類別的零售額將達到181億歐元，凸顯了市場對頭皮和頭髮護理解決方案的巨大經濟需求。這一強勁表現表明，消費者正強烈轉向那些除了基本清潔之外，還能提供經證實有效的治療功效的產品。

市場概覽
預測期 2027-2031
市場規模：2025年 267.5億美元
市場規模：2031年 366.1億美元
複合年成長率：2026-2031年 5.37%
成長最快的細分市場 線上
最大的市場 北美洲

然而，由於對醫療功效和活性成分核准的嚴格監管，市場擴張面臨許多障礙。製造商必須進行嚴苛的臨床試驗和安全性檢驗以證明療效，這導致營運成本高且研發週期漫長。這種複雜的合規環境提高了市場進入門檻，並限制了新治療方法在全球推廣的速度。

市場促進因素

慢性頭皮疾病（如頭皮屑、乾癬和脂漏性皮膚炎）的日益普遍是推動全球藥用洗髮精市場擴張的主要因素。由於生活方式的改變和環境壓力，這些疾病影響全球越來越多的人口，因此，含有活性藥物成分的治療性護髮配方需求顯著增加。日益加重的疾病負擔迫使消費者從普通洗髮精轉向功能性治療產品，以控制諸如鱗屑和發炎等症狀。根據美國國家銀屑病基金會2024年8月發布的《銀屑病健康指數報告》，美國約有750萬成年人（約佔成年人口的3%）患有銀屑病，證實了專業治療方案的巨大市場潛力。

同時，皮膚科醫生推薦和臨床處方箋的快速成長，使得準藥物護髮產品從可有可無的衛生用品躍升為必不可少的健康維護品。製造商正透過嚴格的測試來加強產品檢驗，以獲得醫療核准，這顯著影響消費者的購買決策。這種「醫療化」趨勢使得擁有可靠臨床記錄的品牌能夠實現高於整體市場的成長速度。例如，歐萊雅於2024年2月發布的2023年度報告指出，其皮膚科和美容部門的同店銷售額成長了28.4%，這主要得益於消費者對專家推薦處方的需求。同樣，寶潔公司報告稱，其護髮部門在2024年實現了接近兩位數的有機銷售額成長，這主要得益於高級產品和功效型產品組合的良好表現。

市場挑戰

嚴格的活性成分核准和醫療聲明監管框架對全球準藥品洗髮精市場的成長構成重大障礙。製造商必須進行複雜的臨床試驗和安全性檢驗，以證明治療配方的有效性。這項嚴苛的流程不可避免地增加了營運成本，並顯著延長了研發週期，使企業無法快速回應不斷變化的消費者需求。因此，合規帶來的經濟負擔抑制了對新活性成分的投資，阻礙了可能推動市場廣泛接受的創新治療方法的推出。

這種高合規性環境顯著提高了准入門檻，尤其對於往往缺乏足夠資金儲備來應對漫長核准流程的中小型企業而言更是如此。考慮到產業的組成，這種情況尤其嚴峻：根據歐洲化妝品協會（Cosmetics Europe）統計，截至2024年，歐洲個人護理行業由超過9600家中小企業組成。如此眾多的小規模市場參與企業極易受到監管壓力的影響，這限制了它們推出小眾護理產品的能力，最終導致全球消費者可選擇的解決方案種類有限，並阻礙了整體市場擴張。

市場趨勢

全球藥用洗髮精市場正因微生物友善和益生菌產品的興起而重塑。產品研發的重點正從簡單的病原體清除轉向管理頭皮的整個生態系統。製造商越來越重視保護角質層和平衡頭皮天然菌叢的配方，而不是僅僅使用刺激性活性成分來消除細菌和真菌。這種科學演進與「護髮護膚」的概念相契合，後者利用傳統用於臉部護膚的成分，例如益生元和尿素，來修復頭皮屏障。這種對皮膚科功效的關注正在帶來顯著的商業性成果。根據拜爾斯道夫股份公司於2025年2月發布的2024年度報告，該公司旗下包括絲胺酸品牌在內的皮膚護理部門實現了10.6%的有機銷售成長，證實了消費者對具有科學先進性的屏障支持護理產品的需求日益成長。

同時，多功能護理產品的開發正在加速優質化，因為消費者越來越傾向在追求頭皮健康的同時，也注重秀髮的美觀。市場正見證藥用效用與美容美感的融合。全新配方在解決潛在問題的同時，也能帶來沙龍級的豐盈、護色和改善髮質等效果。這一趨勢打破了以往臨床洗髮精的刺激性和普通護髮產品的美容效果之間的權衡，從而推動了產品的持續使用和高階定價。根據聯合利華公司於2025年2月發布的“2024會計年度全年業績報告”，其美容與健康事業部實現了6.5%的銷售額成長。這主要得益於其核心產品組合的成功優質化，其中包括將健康功效與卓越美容效果相結合的全新頭皮護理產品。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球藥用洗髮精市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依產品類型（頭皮屑/脂漏性皮膚炎、乾癬、其他）
    • 依銷售管道（超級市場/大賣場、藥局/藥局、百貨公司、線上、其他（直銷等））
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美藥用洗髮精市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲藥用洗髮精市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章 亞太地區藥用洗髮精市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲藥用洗髮精市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲藥用洗髮精市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球藥用洗髮精市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Procter & Gamble
  • Johnson & Johnson
  • Himalaya Herbal Healthcare
  • Farnam Companies, Inc.
  • Sanofi-Aventis Groupe
  • Summers Laboratories Inc.
  • Maruho Co. Ltd.
  • Kao Corporation
  • Coty Inc.
  • Avalon Natural Products, Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 16343

The Global Medicated Shampoo Market is projected to expand from USD 26.75 Billion in 2025 to USD 36.61 Billion by 2031, registering a CAGR of 5.37%. This industry segment is defined by therapeutic hair care formulations containing active agents specifically engineered to treat scalp pathologies such as dandruff, psoriasis, and seborrheic dermatitis. Key drivers propelling market growth include the increasing prevalence of scalp ailments and rising consumer spending on functional personal care products that provide specific health advantages. Data from Cosmetics Europe indicates that the European hair care category generated retail sales of €18.1 billion in 2024, highlighting the substantial economic demand for solutions addressing scalp and hair maintenance. This robust performance signals a strong consumer shift toward products that deliver proven therapeutic results beyond basic hygiene.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 26.75 Billion
Market Size 2031USD 36.61 Billion
CAGR 2026-20315.37%
Fastest Growing SegmentOnline
Largest MarketNorth America

However, market expansion faces a significant hurdle due to the stringent regulatory framework governing the approval of medical claims and active ingredients. Manufacturers are required to navigate rigorous clinical testing and safety validations to substantiate efficacy, resulting in high operational costs and extended development timelines. This complex compliance environment creates high barriers to entry and limits the speed at which new treatments can be introduced to the global consumer base.

Market Driver

The growing prevalence of chronic scalp ailments, such as dandruff, psoriasis, and seborrheic dermatitis, acts as the primary catalyst for the expansion of the Global Medicated Shampoo Market. As these conditions affect a larger portion of the global population due to lifestyle changes and environmental stressors, there is a critical need for therapeutic hair care formulations containing active pharmaceutical ingredients. This rising disease burden compels consumers to switch from cosmetic shampoos to functional treatments designed to manage symptoms like desquamation and inflammation. According to the National Psoriasis Foundation's 'Psoriasis Health Indicator Report' from August 2024, approximately 7.5 million adults in the United States, or about 3% of the adult population, are affected by psoriasis, underscoring the significant addressable market for specialized management solutions.

Concurrently, a surge in dermatologist recommendations and clinical prescriptions is elevating medicated hair care from optional hygiene to essential health maintenance. Manufacturers are increasingly validating their products through rigorous testing to secure medical endorsements, which significantly influences consumer purchasing decisions. This trend toward "medicalization" allows brands with strong clinical heritage to outperform the broader market. For instance, L'Oreal's '2023 Annual Report' released in February 2024 noted that its Dermatological Beauty division achieved 28.4% like-for-like sales growth, driven by demand for expert-recommended formulations. Similarly, Procter & Gamble reported high single-digit organic sales growth in its Hair Care segment in 2024, fueled by a favorable mix of premium and performance-centric products.

Market Challenge

The stringent regulatory framework controlling the approval of active ingredients and medical claims acts as a major impediment to the growth of the Global Medicated Shampoo Market. Manufacturers must navigate complex clinical testing and safety validations to prove the efficacy of their therapeutic formulations. This rigorous process inevitably results in inflated operational costs and significantly prolonged development timelines, preventing companies from swiftly responding to emerging consumer needs. Consequently, the financial burden associated with compliance discourages investment in novel active agents, thereby stalling the introduction of innovative treatments that could drive broader market adoption.

This high-compliance environment establishes formidable barriers to entry, particularly for smaller entities that often lack the capital reserves to sustain extended approval phases. This dynamic is especially critical given the industry's composition; according to Cosmetics Europe, the European personal care industry comprised more than 9,600 small and medium-sized enterprises (SMEs) in 2024. The vulnerability of such a large volume of smaller market participants to these regulatory pressures restricts their ability to launch niche therapeutic products, ultimately limiting the diversity of solutions available to the global consumer base and hampering overall market expansion.

Market Trends

The Global Medicated Shampoo Market is being reshaped by the emergence of microbiome-friendly and probiotic infusions, shifting product development from simple pathogen eradication to holistic scalp ecosystem management. Manufacturers are increasingly prioritizing formulations that preserve the stratum corneum and balance the scalp's natural flora, rather than solely stripping away bacteria or fungi with harsh active agents. This scientific evolution aligns with the "skinification" of hair care, utilizing ingredients traditionally found in facial skincare, such as prebiotics and urea, to repair the scalp barrier. This focus on dermatological efficacy is yielding significant commercial returns; according to Beiersdorf AG's 'Annual Report 2024' from February 2025, the company's Derma business unit, which houses the Eucerin brand, achieved organic sales growth of 10.6%, validating rising consumer demand for scientifically advanced, barrier-supporting care.

Simultaneously, the development of multi-functional therapeutic products is driving premiumization as consumers refuse to compromise on hair aesthetics for the sake of scalp health. The market is witnessing a convergence of medicinal utility and cosmetic elegance, where new formulations are designed to treat underlying pathologies while delivering salon-grade benefits such as volumizing, color protection, and texture enhancement. This trend addresses the historical trade-off between the unpleasant sensory attributes of clinical shampoos and the beautifying effects of standard hair care, encouraging consistent usage and higher price points. According to Unilever PLC's 'Full Year 2024 Results' released in February 2025, the Beauty & Wellbeing division reported underlying sales growth of 6.5%, attributed to the successful premiumization of core portfolios including new scalp-focused innovations that combine health benefits with superior cosmetic results.

Key Market Players

  • Procter & Gamble
  • Johnson & Johnson
  • Himalaya Herbal Healthcare
  • Farnam Companies, Inc.
  • Sanofi-Aventis Groupe
  • Summers Laboratories Inc.
  • Maruho Co. Ltd.
  • Kao Corporation
  • Coty Inc.
  • Avalon Natural Products, Inc.

Report Scope

In this report, the Global Medicated Shampoo Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Medicated Shampoo Market, By Product Type

  • Dandruff & Seborrheic Dermatitis
  • Psoriasis
  • Others

Medicated Shampoo Market, By Sales Channel

  • Supermarkets/Hypermarkets
  • Pharmacy & Drug Stores
  • Departmental Stores
  • Online
  • Others (Direct Sales etc.)

Medicated Shampoo Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Medicated Shampoo Market.

Available Customizations:

Global Medicated Shampoo Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Medicated Shampoo Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Dandruff & Seborrheic Dermatitis, Psoriasis, Others)
    • 5.2.2. By Sales Channel (Supermarkets/Hypermarkets, Pharmacy & Drug Stores, Departmental Stores, Online, Others (Direct Sales etc.))
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Medicated Shampoo Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By Sales Channel
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Medicated Shampoo Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By Sales Channel
    • 6.3.2. Canada Medicated Shampoo Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By Sales Channel
    • 6.3.3. Mexico Medicated Shampoo Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By Sales Channel

7. Europe Medicated Shampoo Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Sales Channel
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Medicated Shampoo Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Sales Channel
    • 7.3.2. France Medicated Shampoo Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Sales Channel
    • 7.3.3. United Kingdom Medicated Shampoo Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Sales Channel
    • 7.3.4. Italy Medicated Shampoo Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By Sales Channel
    • 7.3.5. Spain Medicated Shampoo Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By Sales Channel

8. Asia Pacific Medicated Shampoo Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Sales Channel
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Medicated Shampoo Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Sales Channel
    • 8.3.2. India Medicated Shampoo Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Sales Channel
    • 8.3.3. Japan Medicated Shampoo Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Sales Channel
    • 8.3.4. South Korea Medicated Shampoo Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Sales Channel
    • 8.3.5. Australia Medicated Shampoo Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Sales Channel

9. Middle East & Africa Medicated Shampoo Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Sales Channel
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Medicated Shampoo Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Sales Channel
    • 9.3.2. UAE Medicated Shampoo Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Sales Channel
    • 9.3.3. South Africa Medicated Shampoo Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Sales Channel

10. South America Medicated Shampoo Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Sales Channel
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Medicated Shampoo Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Sales Channel
    • 10.3.2. Colombia Medicated Shampoo Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Sales Channel
    • 10.3.3. Argentina Medicated Shampoo Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Sales Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Medicated Shampoo Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Procter & Gamble
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Johnson & Johnson
  • 15.3. Himalaya Herbal Healthcare
  • 15.4. Farnam Companies, Inc.
  • 15.5. Sanofi-Aventis Groupe
  • 15.6. Summers Laboratories Inc.
  • 15.7. Maruho Co. Ltd.
  • 15.8. Kao Corporation
  • 15.9. Coty Inc.
  • 15.10. Avalon Natural Products, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer